Tapewire

Nasdaq · USD

ADTN

ADTRAN Holdings, Inc.

Export transactions ↓
Tapewire entity
5331
SEC CIK
0000926282
Parsed reports
653

Last 12 months

Inside the activity.

4 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202530
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202610
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 31, 2020 Filed Jan 5, 2021 20:00 UTC Exercise / conversionDividend Equivalent Rights · Derivative 318.161 $0.00 $0.00
Disclosure

SEC source: 0000926282-21-000004 · primary_doc.xml · derivative · entry 4

Walker Kathryn A · CIK 0001264261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 318.161 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 20:00 UTC GrantCommon Stock 6,094 $0.00 $0.00
Disclosure

SEC source: 0000926282-21-000004 · primary_doc.xml · nonDerivative · entry 3

Walker Kathryn A · CIK 0001264261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,386

F2 · security: Represents restricted stock award grant that vests in full on the first anniversary of the date of grant.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 20:00 UTC Disposition to issuerCommon Stock 0.161 $14.77 $2.38
Disclosure

SEC source: 0000926282-21-000004 · primary_doc.xml · nonDerivative · entry 2

Walker Kathryn A · CIK 0001264261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,292

F1 · security: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 20:00 UTC Exercise / conversionCommon Stock 318.161 Not disclosed Not disclosed
Disclosure

SEC source: 0000926282-21-000004 · primary_doc.xml · nonDerivative · entry 1

Walker Kathryn A · CIK 0001264261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,292.161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 19:43 UTC
Nair BalanDirector
Exercise / conversionDividend Equivalent Rights · Derivative 318.161 $0.00 $0.00
Disclosure

SEC source: 0000926282-21-000003 · primary_doc.xml · derivative · entry 4

Nair Balan · CIK 0001398905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 318.161 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 19:43 UTC
Nair BalanDirector
GrantCommon Stock 6,094 $0.00 $0.00
Disclosure

SEC source: 0000926282-21-000003 · primary_doc.xml · nonDerivative · entry 3

Nair Balan · CIK 0001398905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,323

F2 · security: Represents restricted stock award grant that vests in full on the first anniversary of the date of grant.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 19:43 UTC
Nair BalanDirector
Disposition to issuerCommon Stock 0.161 $14.77 $2.38
Disclosure

SEC source: 0000926282-21-000003 · primary_doc.xml · nonDerivative · entry 2

Nair Balan · CIK 0001398905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,229

F1 · security: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 19:43 UTC
Nair BalanDirector
Exercise / conversionCommon Stock 318.161 Not disclosed Not disclosed
Disclosure

SEC source: 0000926282-21-000003 · primary_doc.xml · nonDerivative · entry 1

Nair Balan · CIK 0001398905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,229.161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 19:21 UTC Exercise / conversionDividend Equivalent Rights · Derivative 318.161 $0.00 $0.00
Disclosure

SEC source: 0000926282-21-000002 · primary_doc.xml · derivative · entry 4

HUSS H FENWICK · CIK 0001201037 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 318.161 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 19:21 UTC GrantCommon Stock 6,094 $0.00 $0.00
Disclosure

SEC source: 0000926282-21-000002 · primary_doc.xml · nonDerivative · entry 3

HUSS H FENWICK · CIK 0001201037 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,323

F2 · security: Represents restricted stock award grant that vests in full on the first anniversary of the date of grant.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 19:21 UTC Disposition to issuerCommon Stock 0.161 $14.77 $2.38
Disclosure

SEC source: 0000926282-21-000002 · primary_doc.xml · nonDerivative · entry 2

HUSS H FENWICK · CIK 0001201037 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,229

F1 · security: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 19:21 UTC Exercise / conversionCommon Stock 318.161 Not disclosed Not disclosed
Disclosure

SEC source: 0000926282-21-000002 · primary_doc.xml · nonDerivative · entry 1

HUSS H FENWICK · CIK 0001201037 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,229.161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 10:38 UTC GrantDividend Equivalent Rights · Derivative 64.783 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000040 · primary_doc.xml · derivative · entry 1

NICHOLS ROY J · CIK 0000937725 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318.161

Underlying: Common Stock · 64.783 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 4, 2020 00:18 UTC Amendment
Foliano MichaelChief Financial Officer
GrantPhantom Stock · Derivative 120.597 $12.96 $1,562.94
Disclosure

SEC source: 0000926282-20-000052 · primary_doc.xml · derivative · entry 5

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,538.946

Underlying: Common Stock · 120.597 shares

Expires not disclosed

F3 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof.

F4 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

F4 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

Read SEC document
December 01, 2020 Filed Dec 4, 2020 00:18 UTC Amendment
Foliano MichaelChief Financial Officer
GrantCommon Stock 1.635 $11.76 $19.23
Disclosure

SEC source: 0000926282-20-000052 · primary_doc.xml · nonDerivative · entry 3

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · 401(k) Plan

Disclosed balance after: 241.443

F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 4, 2020 00:18 UTC Amendment
Foliano MichaelChief Financial Officer
GrantCommon Stock 20.63 $12.71 $262.21
Disclosure

SEC source: 0000926282-20-000052 · primary_doc.xml · nonDerivative · entry 2

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,164.63

F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 23:55 UTC Amendment
Wilson James Denson JrChief Revenue Officer
GrantPhantom Stock · Derivative 115.368 $12.96 $1,495.17
Disclosure

SEC source: 0000926282-20-000051 · primary_doc.xml · derivative · entry 6

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,729.578

Underlying: Common Stock · 115.368 shares

Expires not disclosed

F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

F3 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof.

F4 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

F4 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 23:55 UTC Amendment
Wilson James Denson JrChief Revenue Officer
GrantCommon Stock 27.139 $12.96 $351.72
Disclosure

SEC source: 0000926282-20-000051 · primary_doc.xml · nonDerivative · entry 4

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · 401(k) Plan

Disclosed balance after: 4,009.26

F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 23:55 UTC Amendment
Wilson James Denson JrChief Revenue Officer
GrantCommon Stock 26.9 $12.71 $341.90
Disclosure

SEC source: 0000926282-20-000051 · primary_doc.xml · nonDerivative · entry 3

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,049

F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 23:13 UTC
Scheiterer EduardSVP, Research & Development
GrantCommon Stock 19.13 $12.71 $243.14
Disclosure

SEC source: 0000926282-20-000050 · primary_doc.xml · nonDerivative · entry 1

Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,597.13

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 23:07 UTC
Harris RayChief Information Officer
GrantCommon Stock 2.367 $12.85 $30.42
Disclosure

SEC source: 0000926282-20-000049 · primary_doc.xml · nonDerivative · entry 1

Harris Ray · CIK 0001766181 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,479.464

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 23:01 UTC
Centis RonaldSVP, Operations
GrantCommon Stock 2.498 $12.85 $32.10
Disclosure

SEC source: 0000926282-20-000048 · primary_doc.xml · nonDerivative · entry 1

Centis Ronald · CIK 0001769038 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,985.257

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 21:22 UTC Amendment
STANTON THOMAS RDirector · Chairman and CEO
GrantPhantom Stock · Derivative 686.271 $12.71 $8,722.50
Disclosure

SEC source: 0000926282-20-000047 · primary_doc.xml · derivative · entry 5

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,516.977

Underlying: Common Stock · 686.271 shares

Expires not disclosed

F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

F3 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof.

F4 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

F4 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 21:22 UTC Amendment
STANTON THOMAS RDirector · Chairman and CEO
GrantCommon Stock 123.78 $12.71 $1,573.24
Disclosure

SEC source: 0000926282-20-000047 · primary_doc.xml · nonDerivative · entry 3

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 285,213.78

F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 16:59 UTC GrantDividend Equivalent Rights · Derivative 64.783 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000045 · primary_doc.xml · derivative · entry 2

McCray Gregory James · CIK 0001327057 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318.161

Underlying: Common Stock · 64.783 shares

Expires not disclosed

F2 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F2 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F2 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 16:59 UTC GrantCommon Stock 52.78 $12.71 $670.83
Disclosure

SEC source: 0000926282-20-000045 · primary_doc.xml · nonDerivative · entry 1

McCray Gregory James · CIK 0001327057 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,233.217

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 16:32 UTC GrantDividend Equivalent Rights · Derivative 64.783 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000044 · primary_doc.xml · derivative · entry 1

Jacqueline Hourigan Rice · CIK 0001637150 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318.161

Underlying: Common Stock · 64.783 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 16:15 UTC GrantDividend Equivalent Rights · Derivative 64.783 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000043 · primary_doc.xml · derivative · entry 1

Walker Kathryn A · CIK 0001264261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318.161

Underlying: Common Stock · 64.783 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 16:07 UTC
Nair BalanDirector
GrantDividend Equivalent Rights · Derivative 64.783 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000042 · primary_doc.xml · derivative · entry 1

Nair Balan · CIK 0001398905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318.161

Underlying: Common Stock · 64.783 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 15:55 UTC GrantDividend Equivalent Rights · Derivative 64.783 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000041 · primary_doc.xml · derivative · entry 1

HUSS H FENWICK · CIK 0001201037 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318.161

Underlying: Common Stock · 64,783 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
December 01, 2020 Filed Sep 7, 2021 17:25 UTC
Kimpe MarcSVP, Research & Development
GrantCommon Stock 11.124 $12.86 $143.05
Disclosure

SEC source: 0000926282-21-000038 · primary_doc.xml · nonDerivative · entry 1

Kimpe Marc · CIK 0001770330 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,725.624

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
November 16, 2020 Filed Nov 17, 2020 22:24 UTC
Harris RayChief Information Officer
Disposition to issuerCommon Stock 2,270 $12.39 $28,130.07
Disclosure

SEC source: 0000926282-20-000032 · primary_doc.xml · nonDerivative · entry 1

Harris Ray · CIK 0001766181 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,671

Read SEC document
November 16, 2020 Filed Nov 19, 2020 02:33 UTC
Wilson James Denson JrChief Revenue Officer
GrantPhantom Stock · Derivative 4,025 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000039 · primary_doc.xml · derivative · entry 2

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,639.21

Underlying: Common Stock · 4,025 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock or the cash value thereof.

F4 · price: Upon vesting of performance shares awarded pursuant to a grant of November 11, 2017 under the ADTRAN, Inc. 2015 Employee Stock Incentive Plan, the reporting person deferred the receipt of shares of the Company's common stock and received instead shares of phantom stock pursuant to the Company's deferred compensation plan.

F3 · derivative.exercise_date: The phantom stock becomes payable 6 months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time.

F3 · derivative.expiration_date: The phantom stock becomes payable 6 months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time.

Read SEC document
November 16, 2020 Filed Nov 19, 2020 02:33 UTC
Wilson James Denson JrChief Revenue Officer
GrantCommon Stock 10,816 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000039 · primary_doc.xml · nonDerivative · entry 1

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,180

F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant.

Read SEC document
November 16, 2020 Filed Nov 19, 2020 02:20 UTC
STANTON THOMAS RDirector · Chairman and CEO
GrantPhantom Stock · Derivative 18,702 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000038 · primary_doc.xml · derivative · entry 2

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,532.706

Underlying: Common Stock · 18,702 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock or the cash value thereof.

F4 · price: Upon vesting of performance shares awarded pursuant to a grant of November 11, 2017 under the ADTRAN, Inc. 2015 Employee Stock Incentive Plan, the reporting person deferred the receipt of shares of the Company's common stock and received instead shares of phantom stock pursuant to the Company's deferred compensation plan.

F3 · derivative.exercise_date: The phantom stock becomes payable 6 months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time.

F3 · derivative.expiration_date: The phantom stock becomes payable 6 months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time.

Read SEC document
November 16, 2020 Filed Nov 19, 2020 02:20 UTC
STANTON THOMAS RDirector · Chairman and CEO
GrantCommon Stock 50,246 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000038 · primary_doc.xml · nonDerivative · entry 1

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,683

F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant.

Read SEC document
November 16, 2020 Filed Nov 19, 2020 00:42 UTC
Scheiterer EduardSVP, Research & Development
GrantCommon Stock 7,510 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000037 · primary_doc.xml · nonDerivative · entry 2

Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,316

F2 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant.

Read SEC document
November 16, 2020 Filed Nov 19, 2020 00:42 UTC
Scheiterer EduardSVP, Research & Development
GrantCommon Stock 2,729 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000037 · primary_doc.xml · nonDerivative · entry 1

Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,806

F1 · security: Represents vesting of performance shares awarded pursuant to a grant on November 11, 2017 under the ADTRAN, Inc. 2015 Employee Stock Incentive Plan.

Read SEC document
November 16, 2020 Filed Nov 19, 2020 00:32 UTC
Foliano MichaelChief Financial Officer
GrantCommon Stock 14,345 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000036 · primary_doc.xml · nonDerivative · entry 2

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,040

F2 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant.

Read SEC document
November 16, 2020 Filed Nov 19, 2020 00:32 UTC
Foliano MichaelChief Financial Officer
GrantCommon Stock 3,051 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000036 · primary_doc.xml · nonDerivative · entry 1

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,695

F1 · security: Represents vesting of performance shares awarded pursuant to a grant on November 11, 2017 under the ADTRAN, Inc. 2015 Employee Stock Incentive Plan.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 23:35 UTC
Kimpe MarcSVP, Research & Development
GrantCommon Stock 7,153 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000035 · primary_doc.xml · nonDerivative · entry 1

Kimpe Marc · CIK 0001770330 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,697

F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 23:21 UTC
Centis RonaldSVP, Operations
GrantCommon Stock 8,933 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000033 · primary_doc.xml · nonDerivative · entry 1

Centis Ronald · CIK 0001769038 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,982.76

F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 23:29 UTC
Harris RayChief Information Officer
GrantCommon Stock 6,806 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000034 · primary_doc.xml · nonDerivative · entry 1

Harris Ray · CIK 0001766181 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,477.1

F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant.

Read SEC document
November 16, 2020 Filed Dec 4, 2020 00:18 UTC Amendment
Foliano MichaelChief Financial Officer
GrantPhantom Stock · Derivative 3,051 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000052 · primary_doc.xml · derivative · entry 4

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,418.349

Underlying: Common Stock · 3,051 shares

Expires not disclosed

F1 · security: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 3,051 shares of common stock on November 16, 2020, which shares should have been reported as the acquisition of shares of Phantom stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F3 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof.

F4 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

F4 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

Read SEC document
November 16, 2020 Filed Dec 4, 2020 00:18 UTC Amendment
Foliano MichaelChief Financial Officer
GrantCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000052 · primary_doc.xml · nonDerivative · entry 1

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,144

F1 · security: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 3,051 shares of common stock on November 16, 2020, which shares should have been reported as the acquisition of shares of Phantom stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · shares: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 3,051 shares of common stock on November 16, 2020, which shares should have been reported as the acquisition of shares of Phantom stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · balance_after: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 3,051 shares of common stock on November 16, 2020, which shares should have been reported as the acquisition of shares of Phantom stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

Read SEC document
November 16, 2020 Filed Dec 3, 2020 23:55 UTC Amendment
Wilson James Denson JrChief Revenue Officer
GrantPhantom Stock · Derivative 0 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000051 · primary_doc.xml · derivative · entry 5

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,614.21

Underlying: Common Stock · 0 shares

Expires not disclosed

F1 · derivative.exercise_price: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · shares: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · derivative.exercise_date: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · derivative.expiration_date: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · derivative.underlying_shares: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · balance_after: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

Read SEC document
November 16, 2020 Filed Dec 3, 2020 23:55 UTC Amendment
Wilson James Denson JrChief Revenue Officer
Tax withholdingCommon Stock 1,182 $12.51 $14,786.82
Disclosure

SEC source: 0000926282-20-000051 · primary_doc.xml · nonDerivative · entry 2

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,023

Read SEC document
November 16, 2020 Filed Dec 3, 2020 23:55 UTC Amendment
Wilson James Denson JrChief Revenue Officer
GrantCommon Stock 4,025 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000051 · primary_doc.xml · nonDerivative · entry 1

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,205

F1 · security: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

Read SEC document
November 16, 2020 Filed Dec 3, 2020 21:22 UTC Amendment
STANTON THOMAS RDirector · Chairman and CEO
GrantCommon Stock 18,702 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000047 · primary_doc.xml · nonDerivative · entry 1

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,385

F1 · security: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

Read SEC document
November 16, 2020 Filed Mar 8, 2021 22:30 UTC Amendment GrantCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0000926282-21-000019 · primary_doc.xml · nonDerivative · entry 1

Foliano Michael · CIK 0001300513 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,010.88

F1 · security: On December 3, 2020, the reporting person filed a Form 4 incorrectly reporting the amount of securities beneficially owned. This amendment shows the correct number of shares of common stock owned by the reporting person.

F1 · balance_after: On December 3, 2020, the reporting person filed a Form 4 incorrectly reporting the amount of securities beneficially owned. This amendment shows the correct number of shares of common stock owned by the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.